Total Payments
$16,391
2024 Payments
$2,623
Companies
48
Transactions
1,052
Medicare Patients
15,187
Medicare Billing
$941,238
Payment Breakdown by Category
Food & Beverage$15,117 (92.2%)
Travel$1,125 (6.9%)
Education$149.55 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,117 | 1,039 | 92.2% |
| Travel and Lodging | $1,125 | 6 | 6.9% |
| Education | $149.55 | 7 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,993 | 142 | $0 (2024) |
| Amgen Inc. | $1,984 | 118 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,919 | 204 | $0 (2024) |
| Medtronic, Inc. | $1,320 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $912.46 | 54 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $903.72 | 58 | $0 (2024) |
| Boston Scientific Corporation | $874.10 | 39 | $0 (2024) |
| PFIZER INC. | $814.29 | 66 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $736.77 | 72 | $0 (2024) |
| Abbott Laboratories | $663.40 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,623 | 142 | Boston Scientific Corporation ($310.68) |
| 2023 | $2,168 | 126 | Novartis Pharmaceuticals Corporation ($331.40) |
| 2022 | $1,771 | 113 | Amgen Inc. ($267.20) |
| 2021 | $2,150 | 82 | Medtronic, Inc. ($1,228) |
| 2020 | $770.42 | 49 | Janssen Pharmaceuticals, Inc ($218.73) |
| 2019 | $2,106 | 165 | Amgen Inc. ($341.86) |
| 2018 | $2,251 | 173 | Novartis Pharmaceuticals Corporation ($326.69) |
| 2017 | $2,553 | 202 | Novartis Pharmaceuticals Corporation ($429.59) |
All Payment Transactions
1,052 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: Lithoplasty | ||||||
| 11/22/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Not Applicable | ||||||
| 11/22/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: LUX-Dx_CRM | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/13/2024 | BIOTRONIK INC. | Selectra (Device) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Lithoplasty | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.24 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 4,274 | 5,809 | $750,633 | $232,530 |
| 2022 | 34 | 3,821 | 5,071 | $784,932 | $253,055 |
| 2021 | 27 | 3,634 | 4,875 | $709,119 | $256,096 |
| 2020 | 25 | 3,458 | 4,617 | $599,631 | $199,557 |
Total Patients
15,187
Total Services
20,372
Medicare Billing
$941,238
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 677 | 1,183 | $259,077 | $103,652 | 40.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 485 | 502 | $104,918 | $24,580 | 23.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 128 | 364 | $54,600 | $22,155 | 40.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 62 | 62 | $64,170 | $13,896 | 21.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,519 | 2,154 | $71,082 | $13,155 | 18.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 80 | 82 | $33,194 | $10,794 | 32.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 118 | 118 | $21,240 | $6,614 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $16,128 | $5,702 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 83 | $12,450 | $4,460 | 35.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 35 | $9,835 | $3,661 | 37.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 278 | 316 | $15,800 | $3,193 | 20.2% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $14,928 | $3,037 | 20.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 31 | $6,603 | $2,952 | 44.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 142 | 142 | $10,934 | $2,194 | 20.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $3,835 | $1,828 | 47.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 148 | 148 | $8,288 | $1,538 | 18.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $6,018 | $1,412 | 23.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 25 | 36 | $4,781 | $1,370 | 28.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 43 | 76 | $6,612 | $1,207 | 18.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 26 | 47 | $4,841 | $995.40 | 20.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 50 | 51 | $4,131 | $991.44 | 24.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 17 | 29 | $5,278 | $838.39 | 15.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 60 | 62 | $2,384 | $647.90 | 27.2% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 43 | 46 | $3,496 | $591.62 | 16.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 20 | 20 | $1,420 | $405.40 | 28.5% |
About Dr. Prasad Kandula, M.D
Dr. Prasad Kandula, M.D is a Nuclear Cardiology healthcare provider based in Belleville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164518460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prasad Kandula, M.D has received a total of $16,391 in payments from pharmaceutical and medical device companies, with $2,623 received in 2024. These payments were reported across 1,052 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($15,117).
As a Medicare-enrolled provider, Kandula has provided services to 15,187 Medicare beneficiaries, totaling 20,372 services with total Medicare billing of $941,238. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Belleville, IL
- Active Since 10/05/2006
- Last Updated 12/29/2025
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1164518460
Products in Payments
- XARELTO (Drug) $1,919
- ENTRESTO (Drug) $1,557
- Repatha (Biological) $1,111
- ELIQUIS (Drug) $1,029
- Micra (Device) $1,028
- BRILINTA (Drug) $948.37
- LifeVest (Device) $903.72
- Corlanor (Drug) $872.79
- KENGREAL (Drug) $438.65
- LEQVIO (Drug) $436.70
- VERQUVO (Drug) $354.42
- JARDIANCE (Drug) $315.86
- Impella (Device) $290.53
- MULTAQ (Drug) $231.03
- WATCHMAN Access System (Device) $207.44
- VYNDAQEL (Drug) $202.98
- PRADAXA (Drug) $196.23
- CHANTIX (Drug) $195.10
- SYNERGY (Device) $183.49
- PRALUENT (Drug) $175.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.